Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis.
Uchida G, Nakamura M, Yamamura T, Maeda K, Sawada T, Ishikawa E, Furukawa K, Iida T, Mizutani Y, Yamao K, Ishikawa T, Ishizu Y, Honda T, Ishigami M, Kawashima H.
Uchida G, et al.
Inflamm Intest Dis. 2023 Jun 14;8(2):60-68. doi: 10.1159/000531497. eCollection 2023 Oct.
Inflamm Intest Dis. 2023.
PMID: 37901340
Free PMC article.